Osaka, Japan

Miyuki Eiraku

This inventor holds 2 USPTO granted patents. Top assignee: The Green Cross Corporation. Active years: 1993-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Miyuki Eiraku. Retrieved from https://idiyas.com/inventor/miyuki-eiraku

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 12.0

ph-index = 2

Forward Citations = 47(Granted Patents)


Company Filing History:


Years Active: 1993-1994

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations by Miyuki Eiraku

Introduction

Miyuki Eiraku is a prominent inventor based in Osaka, Japan. She has made significant contributions to the field of pharmacology, particularly through her innovative aminopyridine compounds. With a total of two patents to her name, Eiraku's work is recognized for its potential in treating circulatory diseases.

Latest Patents

Eiraku's latest patents focus on aminopyridine compounds that exhibit excellent pharmacological effects while minimizing side effects. The first patent describes an aminopyridine compound represented by a specific formula, where various groups and elements are defined to enhance its effectiveness as a drug for circulatory diseases. The second patent also details another aminopyridine compound with a similar structure, emphasizing its potential as a therapeutic agent.

Career Highlights

Miyuki Eiraku is associated with The Green Cross Corporation, where she continues to develop her innovative ideas. Her work has garnered attention in the pharmaceutical industry, showcasing her dedication to improving health outcomes through scientific research.

Collaborations

Eiraku collaborates with notable colleagues, including Tadahiro Takemoto and Masahiro Eda. These partnerships enhance her research efforts and contribute to the advancement of her projects.

Conclusion

Miyuki Eiraku's contributions to the field of pharmacology through her aminopyridine compounds highlight her innovative spirit and commitment to improving healthcare. Her work continues to inspire advancements in drug development for circulatory diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…